Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
This article was originally published in The Tan Sheet
Executive Summary
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
You may also be interested in...
Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices
Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole
Robitussin CoughGels Dedicated Ads Planned During Cough/Cold Season
Robitussin CoughGels will join Wyeth Consumer Care's established line of cough/cold products on shelves in time for the fall/winter 2003 season, the firm said at the recent National Association of Chain Drug Stores Marketplace show in San Diego
Novartis Triaminic Allerchews With Loratadine Slated To Launch In 2004
Novartis' Triaminic children's cough/coldline will be extended in early 2004 with Allerchews, the brand's first loratadine-containing offering. The product debuted at the National Association of Chain Drug Stores Marketplace in San Diego June 8-10